Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002

Dermatology. 2008;217(1):27-37. doi: 10.1159/000121333. Epub 2008 Mar 18.

Abstract

Background: Cardiovascular diseases or risk factors (CVDR) seem to be more common in psoriasis patients than in the general population.

Objective: We assessed the relationship of psoriasis with CVDR by analysis of healthcare claims data using a cross-sectional, prevalence-based study design.

Patients and methods: The IMS Health and MarketScan claims databases were used to identify adults with psoriasis diagnostic codes. Non-psoriasis controls were matched 3:1 based on age, gender, census region and previous medical insurance coverage. Odds ratios evaluated the relative prevalence of CVDR, and Mantel-Haenszel confidence intervals were estimated.

Results: CVDR prevalence was generally higher in psoriasis patients than controls in both datasets. Odds ratios for atherosclerosis, congestive heart failure, type 2 diabetes, and peripheral vascular disease were >or=1.20 for psoriasis patients. Elevated disease severity was associated with a higher rate of CVDR, but varied somewhat by dataset and condition.

Conclusions: Elevated CVDR rates were found in psoriasis patients compared with controls. This pattern merits further examination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anti-Obesity Agents / therapeutic use
  • Cardiovascular Agents / therapeutic use
  • Cardiovascular Diseases / complications
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / epidemiology*
  • Cross-Sectional Studies
  • Databases as Topic
  • Dermatologic Agents / therapeutic use
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / epidemiology
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • International Classification of Diseases
  • Male
  • Middle Aged
  • Phototherapy / statistics & numerical data
  • Prevalence
  • Psoriasis / complications*
  • Psoriasis / therapy
  • Risk Factors
  • United States / epidemiology

Substances

  • Anti-Obesity Agents
  • Cardiovascular Agents
  • Dermatologic Agents
  • Hypoglycemic Agents